Login / Signup

Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS.

Robert ZivadinovMichael G DwyerEllen CarlElizabeth M PooleSteve CavalierParaskevi BriassouliNiels Bergsland
Published in: Therapeutic advances in neurological disorders (2020)
These findings support the clinical relevance of CGM and WB atrophy and early intervention with teriflunomide in CIS.
Keyphrases
  • randomized controlled trial
  • mass spectrometry
  • multiple sclerosis
  • white matter
  • ms ms
  • resting state
  • cerebral ischemia